Thursday, October 30

Browsing: Cidara

XDC

Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results

23 March 20232 Mins Read

SAN DIEGO, March 23, 2023 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting…

XDC

Cidara Therapeutics Provides Corporate Update and Reports

23 March 202311 Mins Read

SAN DIEGO, March 23, 2023 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting…

XDC

CIDARA THERAPEUTICS, INC. Management’s Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)

23 March 202342 Mins Read

You should read the following discussion and analysis together with our consolidated financial statements and related notes included…

XDC

Cidara Therapeutics expands partnership with WuXi XDC

2 February 20232 Mins Read

CD421 is Cidara’s lead oncology candidate. Credit: National Cancer Institute on Unsplash. Cidara Therapeutics has announced the expansion…

XDC

Cidara Therapeutics and WuXi XDC Expand Collaboration for IND-enabling CMC Development to Advance Cidara’s CD73 Oncology DFC Program

1 February 20235 Mins Read

Cidara Therapeutics, Inc.Agreement builds upon the existing relationship with WuXi XDC for CMC development and GMP manufacturing of…

XDC

Cidara Therapeutics and WuXi XDC Expand Collaboration for

1 February 20235 Mins Read

SAN DIEGO and SHANGHAI, China, Feb. 01, 2023 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology…

About Us

We publish a comprehensive news feed covering all news relevant to the crypto user, covering main industry news, politics and regulation as well as consumer-level “news you can use” (practical stuff), including handy DIY tips, links to useful tools, unbiased reviews and opinions revolving around cryptocurrency. Simple logic and real-world examples are preferred before technical jargon and personal rants.

Browsing: Cidara

Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results

Cidara Therapeutics Provides Corporate Update and Reports

CIDARA THERAPEUTICS, INC. Management’s Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)

Cidara Therapeutics expands partnership with WuXi XDC

Cidara Therapeutics and WuXi XDC Expand Collaboration for IND-enabling CMC Development to Advance Cidara’s CD73 Oncology DFC Program

Cidara Therapeutics and WuXi XDC Expand Collaboration for

430 BTC Added To Treasury Stash

YUGA NFTs and APECOIN INVESTORS: 2/6/2023 Lead Plaintiff Deadline in Securities Class Action – Contact Lieff Cabraser

eBay Plans Exit from NFT Market and Cuts Web3 Staff by 30%

Check rates of Bitcoin, Ethereum, Solana, XRP

Virginia Proposes a Mere $17,192 a Year for New Blockchain and Cryptocurrency Commission

About Us

Popular Topics

What’s New Here!

ClockSwap Launches The First Anonymous Monero P2P Market

BNB Holds Above $1,100 Amid Multi-Year Breakout: Technical Analysis Points to $2,500 Short-Term Target – FXLeaders

Ondo tokenizes over 100 US stocks and ETFs on BNB Chain – TradingView

Solana co-founder Anatoly Yakovenko is a big fan of agentic coding – TechCrunch

Our Partner

Browsing: Cidara

About Us

Popular Topics

What’s New Here!

Subscribe

Our Partner